Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ) just unveiled an announcement.
Beximco Pharmaceuticals Limited has received a directive from the Bangladesh Securities and Exchange Commission (BSEC) to appoint nine independent non-executive directors to its board, which would result in a majority of independent directors. The company challenged this order, and the High Court of Bangladesh granted a temporary stay on the appointments for three months. This decision follows an advisory committee’s recommendations related to labor issues at the Beximco Industrial Park, though Beximco Pharma is not involved with the park. The appointments are also subject to shareholder ratification and regulatory due diligence, highlighting BSEC’s effort to protect investor interests.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited is a leading manufacturer and exporter of generic medicines based in Bangladesh. Established in 1976, the company offers a wide range of products including tablets, capsules, liquids, and more, and engages in contract manufacturing for multinational and global generic pharmaceutical companies. Beximco Pharma operates state-of-the-art facilities certified by international regulatory authorities and exports to over 50 countries, employing more than 6000 people.
YTD Price Performance: -1.28%
Average Trading Volume: 59,390
Technical Sentiment Consensus Rating: Sell
For an in-depth examination of BXP stock, go to TipRanks’ Stock Analysis page.
